Weeks later from the newly proposed dietary supplement act, McCain and other supporters backed down to make changes to a bill as what most industry insiders considered to place unnecessary restraints on the dietary supplement manufacturers.
Reasons for the originally proposed legislation were not solid enough to place such restrictions on an industry who in comparison to its counterpart – Big Pharma, strive to provide ingredients with less harsh side-effects in their products. Duplicating what the FDA has already in place is not necessarily the answer to regulating the industry rather than making sure the agency does its job effectively and by the rules already in place.
Advertisement
